$CYRX News

Cryoport (CYRX) Q2 2026 Earnings Call Transcript

CryoPort (CYRX) Upgraded to Buy: Here's Why

Cryoport, Inc. (CYRX) Q2 2026 Earnings Call Transcript

Investor Confidence in CryoPort (CYRX) Strengthened Backed by Pipeline Expansion

Guggenheim Maintains Buy on CryoPort, Raises Price Target to $16

Cryoport, Inc. Q2 2026 Earnings Call Summary

Needham Maintains Buy on CryoPort, Raises Price Target to $19

CryoPort Inc (CYRX) (Q2 2026) Earnings Call Highlights: Positive EBITDA Milestone and 15% ...

CryoPort Q2 Earnings Call Highlights

Cryoport, Inc. 2026 Q2 - Results - Earnings Call Presentation

CryoPort, Inc. (CYRX) Reports Q2 Loss, Beats Revenue Estimates

Cryoport (NASDAQ:CYRX) Reports In-Line Q2 Results as Stock Edges Higher

Cryoport Reports Second Quarter 2026 Financial Results

Conference Call: CryoPort Affirms FY2026 Sales Guidance of $192.000M-$196.000M vs $194.390M Est

CryoPort Q2 Adj. EPS $(0.20) Misses $(0.19) Estimate, Sales $48.971M Beat $48.207M Estimate

Cryoport (CYRX) Stock Fair Value Rises After Analysts Lift Targets On Growth Trends

BTIG Maintains Buy on CryoPort, Raises Price Target to $25

Cryoport to Report Second Quarter 2026 Financial Results on August 6, 2026

Cryoport's IntegriCell® Cryopreservation Services Selected by Verismo Therapeutics to Support Clinical KIR-CAR T Cell Therapy Programs

Cryoport’s IntegriCell Cryopreservation Services Selected By Verismo Therapeutics To Support SynKIR-110 And SynKIR-310 Multi-Chain KIR-CAR Programs